Motorcar Parts of America to Report Fiscal 2015 First

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Motorcar Parts of America to Report Fiscal 2015 First Quarter Results; Host Conference Call

LOS ANGELES, Aug. 6, 2014 (GLOBE NEWSWIRE) -- Motorcar Parts of America, Inc. (Nasdaq: MPAA ) today announced the company will issue results for its fiscal 2015 first quarter on Monday, August 11, 2014.

Selwyn Joffe, chairman, president and chief executive officer, and David Lee, chief financial officer, will host an investor conference call the same day at 10:00 a.m. Pacific time to discuss the company's financial results and operations.

The call will be open to all interested investors either through a live audio Web broadcast at www.motorcarparts.com or live by calling (877)-776-4016 (domestic) or (973)-638-3231 (international). For those who are not available to listen to the live broadcast, the call will be archived for seven days on Motorcar Parts of America's website www.motorcarparts.com . A telephone playback of the conference call will also be available from approximately 1:00 p.m. Pacific time today through 8:59 p.m. Pacific time on Monday, August 18, 2014 by calling (855)-859-2056 (domestic) or (404)-537-3406 (international) and using access code: 81621123

About Motorcar Parts of America

Motorcar Parts of America, Inc. is a remanufacturer, manufacturer and distributor of automotive aftermarket parts -- including alternators, starters and wheel hub assembly products utilized in imported and domestic passenger vehicles, light trucks and heavy duty applications. Motorcar Parts of America's products are sold to automotive retail outlets and the professional repair market throughout the United States and Canada, with production facilities located in California, Mexico, Malaysia and China, and administrative offices located in California, Tennessee, Mexico, Singapore and Malaysia. Additional information is available at www.motorcarparts.com .

Gary S. Maier Maier & Company, Inc. (310) 471-1288

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib

Updated Category News Views 264

Promising Advances in Breast Cancer Treatment Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a pioneering biopharmaceutical company specializing in breast cancer therapies, recently revealed compelling data from its Phase 1b/2 trial examining the effects of palazestrant combined with ribociclib in patients battling estrogen...

Continue Reading
Recent Share Transactions by Danske Bank Management Team

Updated Category News Views 135

Recent Share Transactions by Danske Bank Management Team Danske Bank A/S has been making headlines with its ongoing share buy-back program, a key strategic move aimed at enhancing shareholder value. As management and executives involve themselves in these transactions, it is essential to stay informed about their actions, which are a reflection of the company's health and...

Continue Reading
Purpose Legal's PurposeXi: AI-Driven Legal Revolution or Just Hype?

Updated Category News Views 171

Purpose Legal just unveiled PurposeXi™ on February 17, 2026—this shiny new tool aims to revolutionize the legal landscape by integrating AI across the board. Traders are raising eyebrows because while they tout speed and efficiency, we've seen this play before. Remember when tech made bold claims but left investors hanging when reality hit? Well, buckle up....

Continue Reading
PowerBank's Vision for Dominating the Data Center Industry

Updated Category News Views 138

Insight into the Data Center Market PowerBank Corporation (NASDAQ: SUUN) is stepping into the spotlight as a key player in the rapidly expanding data center market. The company is poised to leverage its expertise in energy infrastructure development and asset ownership to address the rising demand for power supply in data centers. Projections suggest that the data center...

Continue Reading
Exploring the Promising Landscape of Adenosine Antagonists

Updated Category News Views 156

Introduction to Adenosine Antagonists Adenosine antagonists represent a fascinating domain in medical research, particularly due to their potential implications across various therapeutic areas. As these compounds inhibit adenosine—a nucleoside that governs essential physiological functions—they may revolutionize treatment options for diseases such as cancer,...

Continue Reading